Bill

Bill > SB830


MO SB830

Modifies provisions relating to ketamine


summary

Introduced
02/27/2025
In Committee
03/27/2025
Crossed Over
Passed
Dead
05/16/2025

Introduced Session

2025 Regular Session

Bill Summary

Modifies provisions relating to ketamine

AI Summary

This bill modifies Missouri's controlled substance laws, specifically focusing on ketamine administration for mental health purposes. The bill adds three key provisions regarding ketamine: first, physicians cannot delegate the authority to order ketamine hydrochloride for mental health purposes to anyone else under their Drug Enforcement Administration registration; second, if a physician delegates ketamine administration to a certified registered nurse anesthetist, the physician must be on-site and immediately available to supervise and respond to patient needs during treatment; and third, intravenous ketamine treatment for mental health cannot be administered without a documented diagnosis and treatment plan from a licensed physician. The bill also maintains existing regulations about controlled substance prescriptions for various medical professionals, such as advanced practice registered nurses and veterinarians, and includes restrictions on self-prescribing and personal use of controlled substances. These new provisions aim to ensure stringent oversight and patient safety when ketamine is used for mental health treatment.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Second Read and Referred S Families, Seniors and Health Committee (on 03/27/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...